DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY

Phase 4

Terminated

Conditions: Multiple Sclerosis

Interventions: Other: No Treatment Arm
Drug: Topical Preparation H arm

First Posted Date: 2016-01-27

Last Posted Date: 2018-01-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT02665221

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Impact of Sleep Workshops in College Students

Not Applicable

Completed

Conditions: Sleep Deprivation
Sleep
Insomnia

Interventions: Behavioral: C-SIP
Other: Dream discussion

First Posted Date: 2016-01-27

Last Posted Date: 2022-07-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 180

Registration Number: NCT02665247

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine Replacement Therapies
Other: Treatment As Usual (TAU)
Behavioral: Text Message Intervention (TMI)

First Posted Date: 2016-01-27

Last Posted Date: 2017-12-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 203

Registration Number: NCT02665208

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Visible Light Study

Not Applicable

Completed

Conditions: Skin Disease
Pigment Disorders

First Posted Date: 2016-01-26

Last Posted Date: 2019-06-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 8

Registration Number: NCT02663921

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Organizational Skill Training (OST) in Schools

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)

Interventions: Behavioral: Organizational Skills Training (OST) Intervention

First Posted Date: 2016-01-26

Last Posted Date: 2020-02-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 35

Registration Number: NCT02663986

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Effect of Electronic Cigarettes on Platelets, Endothelium and Inflammation

Not Applicable

Withdrawn

Conditions: Smoking

Interventions: Device: E-cigarette/tobacco Smoking Exposure

First Posted Date: 2016-01-25

Last Posted Date: 2017-01-27

Lead Sponsor: NYU Langone Health

Registration Number: NCT02662075

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Mobile Health Solutions for Behavioral Skill Implementation Through Homework

Not Applicable

Withdrawn

Conditions: Oppositional Defiant
Conduct Disorder

Interventions: Behavioral: Mobile Health Applictaion

First Posted Date: 2016-01-25

Last Posted Date: 2016-12-29

Lead Sponsor: NYU Langone Health

Registration Number: NCT02662140

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates

Not Applicable

Completed

Conditions: Respiratory Distress Syndrome In Premature Infants
Deglutition Disorders
Respiratory Aspiration
Newborn, Premature

Interventions: Device: NCPAP
Dietary Supplement: Varibar® Thin Liquid Barium Sulfate for Suspension

First Posted Date: 2016-01-22

Last Posted Date: 2019-09-25

Lead Sponsor: NYU Langone Health

Target Recruit Count: 7

Registration Number: NCT02661256

Effects of Swaddling on Infants During Feeding

Not Applicable

Completed

Conditions: Premature Birth

Interventions: Behavioral: Swaddling Intervention for Preterm Infants
Behavioral: Unswaddled Control

First Posted Date: 2016-01-22

Last Posted Date: 2017-01-27

Lead Sponsor: NYU Langone Health

Target Recruit Count: 30

Registration Number: NCT02661360

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Sputum-derived Cellular Targets After Xolair (Omalizumab)

Phase 4

Terminated

Conditions: Asthma

Interventions: Drug: Placebo
Drug: Omalizumab

First Posted Date: 2016-01-20

Last Posted Date: 2019-09-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 3

Registration Number: NCT02658877

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy